Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Jun 2023 for Emergent BioSolutions Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert Kramer: trading record in brief
Robert Kramer is a declared insider of Emergent BioSolutions Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 9 filings, for trades running from 8 May 2021 to 9 June 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 13 June 2023: a share grant, in Emergent BioSolutions Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Kramer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
70,769 shares0Common StockSEC:0001367644-23-000119:0
19,231 shares0Common StockSEC:0001367644-23-000071:0
3,226 shares@ US$12.3831.5% of flowCommon StockSEC:0001367644-23-000055:0
1,428 shares@ US$14.3016.1% of flowCommon StockSEC:0001367644-23-000032:0
278 shares0Common StockSEC:0001367644-23-000017:0
33,833 shares0Common StockSEC:0001367644-22-000044:0
1,419 shares@ US$42.230.013% mcap84.6% of flowCommon StockSEC:0001367644-22-000031:0
4,264 shares0Common StockSEC:0001367644-22-000022:0
94 shares@ US$61.624.2% of flowCommon StockSEC:0001367644-21-000077:0
9 of 9 declarations
